<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://ascptpod.com/wp-content/plugins/seriously-simple-podcasting/templates/feed-stylesheet.xsl"?><rss version="2.0"
	 xmlns:content="http://purl.org/rss/1.0/modules/content/"
	 xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	 xmlns:dc="http://purl.org/dc/elements/1.1/"
	 xmlns:atom="http://www.w3.org/2005/Atom"
	 xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	 xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	 xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
	 xmlns:podcast="https://podcastindex.org/namespace/1.0"
	>
		<channel>
		<title>ClinPharmPod</title>
		<atom:link href="https://ascptpod.com/feed/podcast/clinpharmpod/" rel="self" type="application/rss+xml"/>
		<link>https://ascptpod.com/series/clinpharmpod/</link>
		<description>ClinPharmPod is our channel from &lt;a href=&quot;https://ascpt.onlinelibrary.wiley.com/journal/15326535&quot; target=&quot;_blank&quot; rel=&quot;noopener noreferrer&quot;&gt;Clinical Pharmacology &amp; Therapeutics&lt;/a&gt;. Join us as we delve into the advances in the nature, action, efficacy, and evaluation of therapeutics in this cross-disciplinary field of experimental and clinical medicine featuring highlighted content from the one of the top journals in clinical pharmacology and therapeutics.</description>
		<lastBuildDate>Fri, 06 Mar 2026 12:00:13 +0000</lastBuildDate>
		<language>en-US</language>
		<copyright>&#xA9; 2026 ASCPT Podcast Channel</copyright>
		<itunes:subtitle>The official podcast stream of the American Society for Clinical Pharmacology &amp; Therapeutics (ASCPT).</itunes:subtitle>
		<itunes:author>ASCPT Podcast Channel</itunes:author>
		<itunes:summary>ClinPharmPod is our channel from &lt;a href=&quot;https://ascpt.onlinelibrary.wiley.com/journal/15326535&quot; target=&quot;_blank&quot; rel=&quot;noopener noreferrer&quot;&gt;Clinical Pharmacology &amp; Therapeutics&lt;/a&gt;. Join us as we delve into the advances in the nature, action, efficacy, and evaluation of therapeutics in this cross-disciplinary field of experimental and clinical medicine featuring highlighted content from the one of the top journals in clinical pharmacology and therapeutics.</itunes:summary>
		<itunes:owner>
			<itunes:name>ASCPT Podcast Channel</itunes:name>
		</itunes:owner>
		<itunes:explicit>false</itunes:explicit>
		<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/clinpharmpod-cover-image.jpg"></itunes:image>
			<image>
				<url>https://ascptpod.com/wp-content/uploads/2020/03/clinpharmpod-cover-image.jpg</url>
				<title>ClinPharmPod</title>
				<link>https://ascptpod.com/series/clinpharmpod/</link>
			</image>
		<itunes:category text="Science">
			<itunes:category text="Medicine"></itunes:category>
		</itunes:category>
		<googleplay:author><![CDATA[ASCPT Podcast Channel]]></googleplay:author>
						<googleplay:description>ClinPharmPod is our channel from &lt;a href=&quot;https://ascpt.onlinelibrary.wiley.com/journal/15326535&quot; target=&quot;_blank&quot; rel=&quot;noopener noreferrer&quot;&gt;Clinical Pharmacology &amp; Therapeutics&lt;/a&gt;. Join us as we delve into the advances in the nature, action, efficacy, and evaluation of therapeutics in this cross-disciplinary field of experimental and clinical medicine featuring highlighted content from the one of the top journals in clinical pharmacology and therapeutics.</googleplay:description>
			<googleplay:explicit>No</googleplay:explicit>
			<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/clinpharmpod-cover-image.jpg"></googleplay:image>
			<podcast:locked>yes</podcast:locked>
		<podcast:guid>8855dcb5-571d-533f-98e1-8714ad83724d</podcast:guid>
		
		<!-- podcast_generator="SSP by Castos/3.14.3" Seriously Simple Podcasting plugin for WordPress (https://wordpress.org/plugins/seriously-simple-podcasting/) -->
		<generator>https://wordpress.org/?v=6.9.4</generator>

<item>
	<title>CTS Call for Papers: Biomarkers</title>
	<link>https://ascptpod.com/podcast/cts-call-for-papers-biomarkers/</link>
	<pubDate>Mon, 19 May 2025 20:37:36 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=381</guid>
	<description><![CDATA[Biomarkers have transformed the landscape of clinical and translational sciences and are accelerating the progress towards targeted and precision medicine. Breakthrough technological advancement coupled with novel data analysis methods is driving innovations in biomarker identification and validation and is increasingly making biomarkers crucial for drug development and improving patient outcomes. Listen as Clinical and Translational [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Biomarkers have transformed the landscape of clinical and translational sciences and are accelerating the progress towards targeted and precision medicine. Breakthrough technological advancement coupled with novel data analysis methods is driving innovat]]></itunes:subtitle>
	<content:encoded><![CDATA[Biomarkers have transformed the landscape of clinical and translational sciences and are accelerating the progress towards targeted and precision medicine. Breakthrough technological advancement coupled with novel data analysis methods is driving innovations in biomarker identification and validation and is increasingly making biomarkers crucial for drug development and improving patient outcomes. Listen as Clinical and Translational [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/381/cts-call-for-papers-biomarkers.mp3" length="8756220" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Biomarkers have transformed the landscape of clinical and translational sciences and are accelerating the progress towards targeted and precision medicine. Breakthrough technological advancement coupled with novel data analysis methods is driving innovations in biomarker identification and validation and is increasingly making biomarkers crucial for drug development and improving patient outcomes. Listen as Clinical and Translational [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>CTS Call for Papers: Biomarkers</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>8:39</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Biomarkers have transformed the landscape of clinical and translational sciences and are accelerating the progress towards targeted and precision medicine. Breakthrough technological advancement coupled with novel data analysis methods is driving innovations in biomarker identification and validation and is increasingly making biomarkers crucial for drug development and improving patient outcomes. Listen as Clinical and Translational [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Bench to Budget: CPT&#8217;s Latest Themed Issue</title>
	<link>https://ascptpod.com/podcast/bench-to-budget-cpts-latest-themed-issue/</link>
	<pubDate>Wed, 30 Apr 2025 23:25:17 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=378</guid>
	<description><![CDATA[Clinical Pharmacology &#38; Therapeutics Associate Editor Rebecca Miksad and Guest Editor Sebastian Schneeweiss stop by clinpharmpod to discuss CPT&#8217;s latest themed issue, which focuses on pharmacoepidemiology and the concept of bench to budget. Learn about the evolution of bench to budget, which articles in the issue caught their eye, and how they see this field [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &#38; Therapeutics Associate Editor Rebecca Miksad and Guest Editor Sebastian Schneeweiss stop by clinpharmpod to discuss CPT&#8217;s latest themed issue, which focuses on pharmacoepidemiology and the concept of bench to budget. Lea]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical Pharmacology &#38; Therapeutics Associate Editor Rebecca Miksad and Guest Editor Sebastian Schneeweiss stop by clinpharmpod to discuss CPT&#8217;s latest themed issue, which focuses on pharmacoepidemiology and the concept of bench to budget. Learn about the evolution of bench to budget, which articles in the issue caught their eye, and how they see this field [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/378/bench-to-budget-cpts-latest-themed-issue.mp3" length="14336110" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &#38; Therapeutics Associate Editor Rebecca Miksad and Guest Editor Sebastian Schneeweiss stop by clinpharmpod to discuss CPT&#8217;s latest themed issue, which focuses on pharmacoepidemiology and the concept of bench to budget. Learn about the evolution of bench to budget, which articles in the issue caught their eye, and how they see this field [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>Bench to Budget: CPT&#8217;s Latest Themed Issue</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>16:38</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &#38; Therapeutics Associate Editor Rebecca Miksad and Guest Editor Sebastian Schneeweiss stop by clinpharmpod to discuss CPT&#8217;s latest themed issue, which focuses on pharmacoepidemiology and the concept of bench to budget. Learn about the evolution of bench to budget, which articles in the issue caught their eye, and how they see this field [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Check Out CPT’s Latest Themed Issue &#8220;Getting the Dose Right&#8221;!</title>
	<link>https://ascptpod.com/podcast/check-out-cpts-latest-themed-issue-getting-the-dose-right/</link>
	<pubDate>Wed, 30 Oct 2024 20:05:30 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=350</guid>
	<description><![CDATA[Clinical Pharmacology &#38; Therapeutics Editors Karthik Venkatakrishnan, Iris Minichmayr, Richard Peck, and Piet van der Graaf stop by clinpharmpod to discuss the latest themed issue from CPT, &#8220;Getting the Dosage Right.&#8221; Learn how the CPT Editorial Team conceived this theme, what areas of study are highlighted in the issue, and how this theme ties into [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &#38; Therapeutics Editors Karthik Venkatakrishnan, Iris Minichmayr, Richard Peck, and Piet van der Graaf stop by clinpharmpod to discuss the latest themed issue from CPT, &#8220;Getting the Dosage Right.&#8221; Learn how the CPT Ed]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical Pharmacology &#38; Therapeutics Editors Karthik Venkatakrishnan, Iris Minichmayr, Richard Peck, and Piet van der Graaf stop by clinpharmpod to discuss the latest themed issue from CPT, &#8220;Getting the Dosage Right.&#8221; Learn how the CPT Editorial Team conceived this theme, what areas of study are highlighted in the issue, and how this theme ties into [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/350/check-out-cpts-latest-themed-issue-getting-the-dose-right.mp3" length="16200430" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &#38; Therapeutics Editors Karthik Venkatakrishnan, Iris Minichmayr, Richard Peck, and Piet van der Graaf stop by clinpharmpod to discuss the latest themed issue from CPT, &#8220;Getting the Dosage Right.&#8221; Learn how the CPT Editorial Team conceived this theme, what areas of study are highlighted in the issue, and how this theme ties into [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Check Out CPT’s Latest Themed Issue &#8220;Getting the Dose Right&#8221;!</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>20:19</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &#38; Therapeutics Editors Karthik Venkatakrishnan, Iris Minichmayr, Richard Peck, and Piet van der Graaf stop by clinpharmpod to discuss the latest themed issue from CPT, &#8220;Getting the Dosage Right.&#8221; Learn how the CPT Editorial Team conceived this theme, what areas of study are highlighted in the issue, and how this theme ties into [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>CPT Rare Diseases Call for Papers</title>
	<link>https://ascptpod.com/podcast/cpt-rare-diseases-call-for-papers/</link>
	<pubDate>Mon, 13 May 2024 17:17:03 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=327</guid>
	<description><![CDATA[Clinical Pharmacology &#38; Therapeutics has an open call for papers on Rare and Orphan Diseases, but the deadline is closing soon! Check out the latest episode of ClinPharmPod, where Editors-in-Training Drs. Mai Mehanna and Ya-Feng (Jay) Wen detail why CPT chose this theme and what types of papers the editors are hoping to receive. If [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &#38; Therapeutics has an open call for papers on Rare and Orphan Diseases, but the deadline is closing soon! Check out the latest episode of ClinPharmPod, where Editors-in-Training Drs. Mai Mehanna and Ya-Feng (Jay) Wen detail why ]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical Pharmacology &#38; Therapeutics has an open call for papers on Rare and Orphan Diseases, but the deadline is closing soon! Check out the latest episode of ClinPharmPod, where Editors-in-Training Drs. Mai Mehanna and Ya-Feng (Jay) Wen detail why CPT chose this theme and what types of papers the editors are hoping to receive. If [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/327/cpt-rare-diseases-call-for-papers.mp3" length="9881662" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &#38; Therapeutics has an open call for papers on Rare and Orphan Diseases, but the deadline is closing soon! Check out the latest episode of ClinPharmPod, where Editors-in-Training Drs. Mai Mehanna and Ya-Feng (Jay) Wen detail why CPT chose this theme and what types of papers the editors are hoping to receive. If [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>CPT Rare Diseases Call for Papers</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>12:03</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &#38; Therapeutics has an open call for papers on Rare and Orphan Diseases, but the deadline is closing soon! Check out the latest episode of ClinPharmPod, where Editors-in-Training Drs. Mai Mehanna and Ya-Feng (Jay) Wen detail why CPT chose this theme and what types of papers the editors are hoping to receive. If [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Building on Biosimilars</title>
	<link>https://ascptpod.com/podcast/building-on-biosimilars/</link>
	<pubDate>Mon, 23 Jan 2023 19:40:13 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=281</guid>
	<description><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its first themed issue of 2023 – Innovations in Biosimilars. Join Editor-in-Chief Dr. Piet van der Graaf and Guest Editor Yow-Ming Wang as they discuss what papers stood out to them, their thoughts around the growing importance of biosimilars in Clinical Pharmacology, and how the editorial team developed that [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its first themed issue of 2023 – Innovations in Biosimilars. Join Editor-in-Chief Dr. Piet van der Graaf and Guest Editor Yow-Ming Wang as they discuss what papers stood out to them, their thoug]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its first themed issue of 2023 – Innovations in Biosimilars. Join Editor-in-Chief Dr. Piet van der Graaf and Guest Editor Yow-Ming Wang as they discuss what papers stood out to them, their thoughts around the growing importance of biosimilars in Clinical Pharmacology, and how the editorial team developed that [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/281/building-on-biosimilars.mp3" length="10133925" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its first themed issue of 2023 – Innovations in Biosimilars. Join Editor-in-Chief Dr. Piet van der Graaf and Guest Editor Yow-Ming Wang as they discuss what papers stood out to them, their thoughts around the growing importance of biosimilars in Clinical Pharmacology, and how the editorial team developed that [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png</url>
		<title>Building on Biosimilars</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>14:51</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its first themed issue of 2023 – Innovations in Biosimilars. Join Editor-in-Chief Dr. Piet van der Graaf and Guest Editor Yow-Ming Wang as they discuss what papers stood out to them, their thoughts around the growing importance of biosimilars in Clinical Pharmacology, and how the editorial team developed that [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Submit Your Novel Modalities Research!</title>
	<link>https://ascptpod.com/podcast/submit-your-novel-modalities-research/</link>
	<pubDate>Mon, 12 Dec 2022 17:38:17 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=278</guid>
	<description><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its September 2023 themed issue on Novel Modalities. Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Sander Vinks, and Editor-in-Training Dr. Sofia Choi to discuss types of submissions they’d most like to see as [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its September 2023 themed issue on Novel Modalities. Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Sander Vink]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its September 2023 themed issue on Novel Modalities. Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Sander Vinks, and Editor-in-Training Dr. Sofia Choi to discuss types of submissions they’d most like to see as [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/278/submit-your-novel-modalities-research.mp3" length="7206729" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its September 2023 themed issue on Novel Modalities. Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Sander Vinks, and Editor-in-Training Dr. Sofia Choi to discuss types of submissions they’d most like to see as [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png</url>
		<title>Submit Your Novel Modalities Research!</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>10:09</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its September 2023 themed issue on Novel Modalities. Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Sander Vinks, and Editor-in-Training Dr. Sofia Choi to discuss types of submissions they’d most like to see as [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Talking Transporters</title>
	<link>https://ascptpod.com/podcast/talking-transporters/</link>
	<pubDate>Wed, 31 Aug 2022 14:14:53 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=270</guid>
	<description><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its third themed issue of 2022 – Transporters. Join Deputy Editor-in-Chief Dr. Kathy Giacomini as she relays what papers caught her eye, her thoughts around the growing importance of transporters in Clinical Pharmacology, and how the editorial team developed that eye-catching cover. If you’re interested in submitting your research [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its third themed issue of 2022 – Transporters. Join Deputy Editor-in-Chief Dr. Kathy Giacomini as she relays what papers caught her eye, her thoughts around the growing importance of transporter]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its third themed issue of 2022 – Transporters. Join Deputy Editor-in-Chief Dr. Kathy Giacomini as she relays what papers caught her eye, her thoughts around the growing importance of transporters in Clinical Pharmacology, and how the editorial team developed that eye-catching cover. If you’re interested in submitting your research [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/270/talking-transporters.mp3" length="7232505" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its third themed issue of 2022 – Transporters. Join Deputy Editor-in-Chief Dr. Kathy Giacomini as she relays what papers caught her eye, her thoughts around the growing importance of transporters in Clinical Pharmacology, and how the editorial team developed that eye-catching cover. If you’re interested in submitting your research [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png</url>
		<title>Talking Transporters</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>10:01</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its third themed issue of 2022 – Transporters. Join Deputy Editor-in-Chief Dr. Kathy Giacomini as she relays what papers caught her eye, her thoughts around the growing importance of transporters in Clinical Pharmacology, and how the editorial team developed that eye-catching cover. If you’re interested in submitting your research [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Sharing Data to Improve Patient-Focused Outcomes</title>
	<link>https://ascptpod.com/podcast/sharing-data-to-improve-patient-focused-outcomes/</link>
	<pubDate>Tue, 26 Apr 2022 11:00:50 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=264</guid>
	<description><![CDATA[Critical Path Institute’s Dr. Diane Stephenson joins host Alaina Webster to discuss the importance of data sharing to improve patient care, particularly in Neuroscience. Diane and her co-authors recently published a Review, “Can Innovative Trial Designs in Orphan Diseases Drive Advancement of Treatments for Common Neurological Diseases?”, in the April Neuroscience-themed issue of Clinical Pharmacology [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Critical Path Institute’s Dr. Diane Stephenson joins host Alaina Webster to discuss the importance of data sharing to improve patient care, particularly in Neuroscience. Diane and her co-authors recently published a Review, “Can Innovative Trial Designs ]]></itunes:subtitle>
	<content:encoded><![CDATA[Critical Path Institute’s Dr. Diane Stephenson joins host Alaina Webster to discuss the importance of data sharing to improve patient care, particularly in Neuroscience. Diane and her co-authors recently published a Review, “Can Innovative Trial Designs in Orphan Diseases Drive Advancement of Treatments for Common Neurological Diseases?”, in the April Neuroscience-themed issue of Clinical Pharmacology [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/264/sharing-data-to-improve-patient-focused-outcomes.mp3" length="10792221" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Critical Path Institute’s Dr. Diane Stephenson joins host Alaina Webster to discuss the importance of data sharing to improve patient care, particularly in Neuroscience. Diane and her co-authors recently published a Review, “Can Innovative Trial Designs in Orphan Diseases Drive Advancement of Treatments for Common Neurological Diseases?”, in the April Neuroscience-themed issue of Clinical Pharmacology [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Sharing Data to Improve Patient-Focused Outcomes</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>14:50</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Critical Path Institute’s Dr. Diane Stephenson joins host Alaina Webster to discuss the importance of data sharing to improve patient care, particularly in Neuroscience. Diane and her co-authors recently published a Review, “Can Innovative Trial Designs in Orphan Diseases Drive Advancement of Treatments for Common Neurological Diseases?”, in the April Neuroscience-themed issue of Clinical Pharmacology [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>2023 Calls for Papers</title>
	<link>https://ascptpod.com/podcast/2023-calls-for-papers/</link>
	<pubDate>Wed, 30 Mar 2022 19:44:12 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=261</guid>
	<description><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched two Calls for Papers. The January 2023 issue of the journal will focus on Biosimilars, and the March 2023 issue will showcase research that highlights Diversity, Equity, and Inclusion in clinical pharmacology and translational science. CPT Editor-in-Chief Piet van der Graaf and Associate Editor Karthik Venkatakrishnan join host [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched two Calls for Papers. The January 2023 issue of the journal will focus on Biosimilars, and the March 2023 issue will showcase research that highlights Diversity, Equity, and Inclusion in clinica]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched two Calls for Papers. The January 2023 issue of the journal will focus on Biosimilars, and the March 2023 issue will showcase research that highlights Diversity, Equity, and Inclusion in clinical pharmacology and translational science. CPT Editor-in-Chief Piet van der Graaf and Associate Editor Karthik Venkatakrishnan join host [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/261/2023-calls-for-papers.mp3" length="9066381" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched two Calls for Papers. The January 2023 issue of the journal will focus on Biosimilars, and the March 2023 issue will showcase research that highlights Diversity, Equity, and Inclusion in clinical pharmacology and translational science. CPT Editor-in-Chief Piet van der Graaf and Associate Editor Karthik Venkatakrishnan join host [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png</url>
		<title>2023 Calls for Papers</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>12:38</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched two Calls for Papers. The January 2023 issue of the journal will focus on Biosimilars, and the March 2023 issue will showcase research that highlights Diversity, Equity, and Inclusion in clinical pharmacology and translational science. CPT Editor-in-Chief Piet van der Graaf and Associate Editor Karthik Venkatakrishnan join host [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>What’s New in Neuroscience?</title>
	<link>https://ascptpod.com/podcast/whats-new-in-neuroscience/</link>
	<pubDate>Sat, 19 Mar 2022 16:00:47 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=257</guid>
	<description><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its second themed issue of 2022 – Therapeutics in Neuroscience. Join Editor-in-Chief Dr. Piet van der Graaf and Associate/Guest Editors Drs. Spiros Vamvakas, Paulien Ravenstijn, and Iris Minichmayr as they delve into reasons for the theme, what papers caught their eyes, and what action items they hope to leave [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its second themed issue of 2022 – Therapeutics in Neuroscience. Join Editor-in-Chief Dr. Piet van der Graaf and Associate/Guest Editors Drs. Spiros Vamvakas, Paulien Ravenstijn, and Iris Minichm]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its second themed issue of 2022 – Therapeutics in Neuroscience. Join Editor-in-Chief Dr. Piet van der Graaf and Associate/Guest Editors Drs. Spiros Vamvakas, Paulien Ravenstijn, and Iris Minichmayr as they delve into reasons for the theme, what papers caught their eyes, and what action items they hope to leave [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/257/whats-new-in-neuroscience.mp3" length="9743266" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its second themed issue of 2022 – Therapeutics in Neuroscience. Join Editor-in-Chief Dr. Piet van der Graaf and Associate/Guest Editors Drs. Spiros Vamvakas, Paulien Ravenstijn, and Iris Minichmayr as they delve into reasons for the theme, what papers caught their eyes, and what action items they hope to leave [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png</url>
		<title>What’s New in Neuroscience?</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>13:07</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &#38; Therapeutics recently published its second themed issue of 2022 – Therapeutics in Neuroscience. Join Editor-in-Chief Dr. Piet van der Graaf and Associate/Guest Editors Drs. Spiros Vamvakas, Paulien Ravenstijn, and Iris Minichmayr as they delve into reasons for the theme, what papers caught their eyes, and what action items they hope to leave [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Calling All Transporter Papers!</title>
	<link>https://ascptpod.com/podcast/calling-all-transporter-papers/</link>
	<pubDate>Tue, 14 Dec 2021 12:00:29 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=250</guid>
	<description><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its September 2022 themed issue on Transporters. Join host Alaina Webster as she welcomes CPT’s Deputy Managing Editor Dr. Kathy Giacomini and Editor-in-Training Dr. Max Smith to discuss types of submissions they’d most like to see as well as why submitting to a [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its September 2022 themed issue on Transporters. Join host Alaina Webster as she welcomes CPT’s Deputy Managing Editor Dr. Kathy Giacomini and Editor-in-Training Dr. Max Sm]]></itunes:subtitle>
	<content:encoded><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its September 2022 themed issue on Transporters. Join host Alaina Webster as she welcomes CPT’s Deputy Managing Editor Dr. Kathy Giacomini and Editor-in-Training Dr. Max Smith to discuss types of submissions they’d most like to see as well as why submitting to a [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/250/calling-all-transporter-papers.mp3" length="3959673" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its September 2022 themed issue on Transporters. Join host Alaina Webster as she welcomes CPT’s Deputy Managing Editor Dr. Kathy Giacomini and Editor-in-Training Dr. Max Smith to discuss types of submissions they’d most like to see as well as why submitting to a [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Calling All Transporter Papers!</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>5:13</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &#38; Therapeutics (CPT) has launched a Call for Papers for its September 2022 themed issue on Transporters. Join host Alaina Webster as she welcomes CPT’s Deputy Managing Editor Dr. Kathy Giacomini and Editor-in-Training Dr. Max Smith to discuss types of submissions they’d most like to see as well as why submitting to a [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Peer Review: What’s Not Helpful in a Review?</title>
	<link>https://ascptpod.com/podcast/peer-review-whats-not-helpful-in-a-review/</link>
	<pubDate>Tue, 14 Sep 2021 11:00:42 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=240</guid>
	<description><![CDATA[ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing feedback, and the tricky topic that is unconscious bias. You can access CPT’s [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing fe]]></itunes:subtitle>
	<content:encoded><![CDATA[ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing feedback, and the tricky topic that is unconscious bias. You can access CPT’s [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/240/peer-review-whats-not-helpful-in-a-review.mp3" length="7274445" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing feedback, and the tricky topic that is unconscious bias. You can access CPT’s [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Peer Review: What’s Not Helpful in a Review?</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>11:06</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing feedback, and the tricky topic that is unconscious bias. You can access CPT’s [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Pharmacogenetics and Underrepresented Populations</title>
	<link>https://ascptpod.com/podcast/pharmacogenetics-and-underrepresented-populations/</link>
	<pubDate>Wed, 08 Sep 2021 14:38:35 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=238</guid>
	<description><![CDATA[Dr. Erica Woodahl is back as moderator to discuss “Applying an equity lens to pharmacogenetic research and translation to underrepresented populations” with Clinical and Translational Science authors Drs. Tiana Luczak and Jacob Brown. They break down the challenges to conducting pharmacogenetic studies in underrepresented populations, what steps researchers can take to overcome these obstacles, and [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Dr. Erica Woodahl is back as moderator to discuss “Applying an equity lens to pharmacogenetic research and translation to underrepresented populations” with Clinical and Translational Science authors Drs. Tiana Luczak and Jacob Brown. They break down the]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Erica Woodahl is back as moderator to discuss “Applying an equity lens to pharmacogenetic research and translation to underrepresented populations” with Clinical and Translational Science authors Drs. Tiana Luczak and Jacob Brown. They break down the challenges to conducting pharmacogenetic studies in underrepresented populations, what steps researchers can take to overcome these obstacles, and [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/238/pharmacogenetics-and-underrepresented-populations.mp3" length="15058725" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Erica Woodahl is back as moderator to discuss “Applying an equity lens to pharmacogenetic research and translation to underrepresented populations” with Clinical and Translational Science authors Drs. Tiana Luczak and Jacob Brown. They break down the challenges to conducting pharmacogenetic studies in underrepresented populations, what steps researchers can take to overcome these obstacles, and [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Pharmacogenetics and Underrepresented Populations</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>20:26</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Dr. Erica Woodahl is back as moderator to discuss “Applying an equity lens to pharmacogenetic research and translation to underrepresented populations” with Clinical and Translational Science authors Drs. Tiana Luczak and Jacob Brown. They break down the challenges to conducting pharmacogenetic studies in underrepresented populations, what steps researchers can take to overcome these obstacles, and [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Peer Review: What’s Most Important in a Review?</title>
	<link>https://ascptpod.com/podcast/peer-review-whats-most-important-in-a-review/</link>
	<pubDate>Tue, 27 Jul 2021 09:01:38 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=235</guid>
	<description><![CDATA[In the second installment of ClinPharmPod’s six-part peer review series, host Alaina Webster is joined by returning guest Dr. Deanna Kroetz, Professor at the University of California, San Francisco in the Department of Bioengineering Therapeutic Sciences and Deputy Editor-in-Chief of Clinical and Translational Science (CTS). They break down the top three things Deanna looks for [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[In the second installment of ClinPharmPod’s six-part peer review series, host Alaina Webster is joined by returning guest Dr. Deanna Kroetz, Professor at the University of California, San Francisco in the Department of Bioengineering Therapeutic Sciences]]></itunes:subtitle>
	<content:encoded><![CDATA[In the second installment of ClinPharmPod’s six-part peer review series, host Alaina Webster is joined by returning guest Dr. Deanna Kroetz, Professor at the University of California, San Francisco in the Department of Bioengineering Therapeutic Sciences and Deputy Editor-in-Chief of Clinical and Translational Science (CTS). They break down the top three things Deanna looks for [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/235/peer-review-whats-most-important-in-a-review.mp3" length="7146285" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In the second installment of ClinPharmPod’s six-part peer review series, host Alaina Webster is joined by returning guest Dr. Deanna Kroetz, Professor at the University of California, San Francisco in the Department of Bioengineering Therapeutic Sciences and Deputy Editor-in-Chief of Clinical and Translational Science (CTS). They break down the top three things Deanna looks for [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Peer Review: What’s Most Important in a Review?</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>9:57</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[In the second installment of ClinPharmPod’s six-part peer review series, host Alaina Webster is joined by returning guest Dr. Deanna Kroetz, Professor at the University of California, San Francisco in the Department of Bioengineering Therapeutic Sciences and Deputy Editor-in-Chief of Clinical and Translational Science (CTS). They break down the top three things Deanna looks for [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Peer Review: Should You Review This Submission?</title>
	<link>https://ascptpod.com/podcast/peer-review-should-you-review-this-submission/</link>
	<pubDate>Tue, 27 Jul 2021 09:00:22 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=232</guid>
	<description><![CDATA[Kicking off a six-part series on peer review, ClinPharmPod host Alaina Webster chats with Dr. Sarah Holstein, Associate Professor at the University of Nebraska Medical Center and Associate Editor for Clinical Pharmacology &#38; Therapeutics (CPT) about the importance of peer review in scientific research and what might constitute a conflict of interest for potential reviewers. [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Kicking off a six-part series on peer review, ClinPharmPod host Alaina Webster chats with Dr. Sarah Holstein, Associate Professor at the University of Nebraska Medical Center and Associate Editor for Clinical Pharmacology &#38; Therapeutics (CPT) about t]]></itunes:subtitle>
	<content:encoded><![CDATA[Kicking off a six-part series on peer review, ClinPharmPod host Alaina Webster chats with Dr. Sarah Holstein, Associate Professor at the University of Nebraska Medical Center and Associate Editor for Clinical Pharmacology &#38; Therapeutics (CPT) about the importance of peer review in scientific research and what might constitute a conflict of interest for potential reviewers. [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/232/peer-review-should-you-review-this-submission.mp3" length="4735941" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Kicking off a six-part series on peer review, ClinPharmPod host Alaina Webster chats with Dr. Sarah Holstein, Associate Professor at the University of Nebraska Medical Center and Associate Editor for Clinical Pharmacology &#38; Therapeutics (CPT) about the importance of peer review in scientific research and what might constitute a conflict of interest for potential reviewers. [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Peer Review: Should You Review This Submission?</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>5:59</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[Kicking off a six-part series on peer review, ClinPharmPod host Alaina Webster chats with Dr. Sarah Holstein, Associate Professor at the University of Nebraska Medical Center and Associate Editor for Clinical Pharmacology &#38; Therapeutics (CPT) about the importance of peer review in scientific research and what might constitute a conflict of interest for potential reviewers. [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>ClinPharmPod: COVID-19 Vaccine Hesitancy and Sociodemographics</title>
	<link>https://ascptpod.com/podcast/clinpharmpod-covid-19-vaccine-hesitancy-and-sociodemographics/</link>
	<pubDate>Fri, 09 Jul 2021 14:47:52 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=229</guid>
	<description><![CDATA[For this episode of ClinPharmPod, host Alaina Webster sits down with Dr. Don Willis, Assistant Professor at the University of Arkansas for Medical Sciences, and moderator Dr. Erica Woodahl, Professor at the University of Montana and Associate Editor for Clinical and Translational Science (CTS). They discuss Don and his colleagues’ recent publication in CTS, “COVID-19 [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[For this episode of ClinPharmPod, host Alaina Webster sits down with Dr. Don Willis, Assistant Professor at the University of Arkansas for Medical Sciences, and moderator Dr. Erica Woodahl, Professor at the University of Montana and Associate Editor for ]]></itunes:subtitle>
	<content:encoded><![CDATA[For this episode of ClinPharmPod, host Alaina Webster sits down with Dr. Don Willis, Assistant Professor at the University of Arkansas for Medical Sciences, and moderator Dr. Erica Woodahl, Professor at the University of Montana and Associate Editor for Clinical and Translational Science (CTS). They discuss Don and his colleagues’ recent publication in CTS, “COVID-19 [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/229/clinpharmpod-covid-19-vaccine-hesitancy-and-sociodemographics.mp3" length="14938149" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[For this episode of ClinPharmPod, host Alaina Webster sits down with Dr. Don Willis, Assistant Professor at the University of Arkansas for Medical Sciences, and moderator Dr. Erica Woodahl, Professor at the University of Montana and Associate Editor for Clinical and Translational Science (CTS). They discuss Don and his colleagues’ recent publication in CTS, “COVID-19 [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>ClinPharmPod: COVID-19 Vaccine Hesitancy and Sociodemographics</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>19:18</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[For this episode of ClinPharmPod, host Alaina Webster sits down with Dr. Don Willis, Assistant Professor at the University of Arkansas for Medical Sciences, and moderator Dr. Erica Woodahl, Professor at the University of Montana and Associate Editor for Clinical and Translational Science (CTS). They discuss Don and his colleagues’ recent publication in CTS, “COVID-19 [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>ClinPharmPod: Journal Submissions in the Time of COVID</title>
	<link>https://ascptpod.com/podcast/clinpharmpod-journal-submissions-in-the-time-of-covid/</link>
	<pubDate>Wed, 30 Sep 2020 13:34:23 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=221</guid>
	<description><![CDATA[On the latest episode of ClinPharmPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &#38; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology &#38; Therapeutics, to discuss their experiences of how COVID-19 has affected [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[On the latest episode of ClinPharmPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &#38; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and S]]></itunes:subtitle>
	<content:encoded><![CDATA[On the latest episode of ClinPharmPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &#38; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology &#38; Therapeutics, to discuss their experiences of how COVID-19 has affected [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/221/clinpharmpod-journal-submissions-in-the-time-of-covid.mp3" length="90068" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On the latest episode of ClinPharmPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &#38; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology &#38; Therapeutics, to discuss their experiences of how COVID-19 has affected [&#8230;]]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/clinpharmpod-cover-image.jpg"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/clinpharmpod-cover-image.jpg</url>
		<title>ClinPharmPod: Journal Submissions in the Time of COVID</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>17:13</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[On the latest episode of ClinPharmPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &#38; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology &#38; Therapeutics, to discuss their experiences of how COVID-19 has affected [&#8230;]]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/clinpharmpod-cover-image.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Reverse Translation Special Joint Episode</title>
	<link>https://ascptpod.com/podcast/reverse-translation-special-joint-episode/</link>
	<pubDate>Thu, 08 Mar 2018 02:37:32 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=184</guid>
	<description><![CDATA[On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Associate Editor for Clinical Pharmacology and Therapeutics, Lang Li, from the Ohio State University and Associate Editor for CPT: Pharmacometrics and Systems Pharmacology, and [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Assoc]]></itunes:subtitle>
	<content:encoded><![CDATA[On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Associate Editor for Clinical Pharmacology and Therapeutics, Lang Li, from the Ohio State University and Associate Editor for CPT: Pharmacometrics and Systems Pharmacology, and [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/184/reverse-translation-special-joint-episode.mp3" length="22324853" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Associate Editor for Clinical Pharmacology and Therapeutics, Lang Li, from the Ohio State University and Associate Editor for CPT: Pharmacometrics and Systems Pharmacology, and [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>18:36</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Associate Editor for Clinical Pharmacology and Therapeutics, Lang Li, from the Ohio State University and Associate Editor for CPT: Pharmacometrics and Systems Pharmacology, and [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Stuart MacLeod on Improving Medicine Use for Children</title>
	<link>https://ascptpod.com/podcast/stuart-macleod-improving-medicine-use-children/</link>
	<pubDate>Tue, 14 Nov 2017 14:34:36 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=161</guid>
	<description><![CDATA[In this episode Dennis Velasco speaks with Stuart MacLeod from the University of British Columbia about efforts to equip pediatric clinical pharmacologists and clinical pharmacists with the necessary skills in relevant research and educational methods to address a shortfall in the human resource pool, particularly in low- and lower-middle-income countries where a majority of children under [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[In this episode Dennis Velasco speaks with Stuart MacLeod from the University of British Columbia about efforts to equip pediatric clinical pharmacologists and clinical pharmacists with the necessary skills in relevant research and educational methods to]]></itunes:subtitle>
	<content:encoded><![CDATA[In this episode Dennis Velasco speaks with Stuart MacLeod from the University of British Columbia about efforts to equip pediatric clinical pharmacologists and clinical pharmacists with the necessary skills in relevant research and educational methods to address a shortfall in the human resource pool, particularly in low- and lower-middle-income countries where a majority of children under [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/161/stuart-macleod-improving-medicine-use-children.mp3" length="27213908" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this episode Dennis Velasco speaks with Stuart MacLeod from the University of British Columbia about efforts to equip pediatric clinical pharmacologists and clinical pharmacists with the necessary skills in relevant research and educational methods to address a shortfall in the human resource pool, particularly in low- and lower-middle-income countries where a majority of children under [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>22:41</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[In this episode Dennis Velasco speaks with Stuart MacLeod from the University of British Columbia about efforts to equip pediatric clinical pharmacologists and clinical pharmacists with the necessary skills in relevant research and educational methods to address a shortfall in the human resource pool, particularly in low- and lower-middle-income countries where a majority of children under [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Marilyn Huestis on Designer Drugs</title>
	<link>https://ascptpod.com/podcast/marilyn-huestis-on-designer-drugs/</link>
	<pubDate>Fri, 21 Apr 2017 14:57:07 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=91</guid>
	<description><![CDATA[In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how they simultaneously offer new pharmacotherapies and pose serious health problems. You can read more in the February issue of CPT focused on Designer Drugs. Listen and subscribe for [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how the]]></itunes:subtitle>
	<content:encoded><![CDATA[In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how they simultaneously offer new pharmacotherapies and pose serious health problems. You can read more in the February issue of CPT focused on Designer Drugs. Listen and subscribe for [&#8230;]]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/91/marilyn-huestis-on-designer-drugs.mp3" length="16192302" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how they simultaneously offer new pharmacotherapies and pose serious health problems. You can read more in the February issue of CPT focused on Designer Drugs. Listen and subscribe for [&#8230;]]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>13:30</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how they simultaneously offer new pharmacotherapies and pose serious health problems. You can read more in the February issue of CPT focused on Designer Drugs. Listen and subscribe for [&#8230;]]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Marlene Haffner on Orphan Drugs</title>
	<link>https://ascptpod.com/podcast/marlene-haffner-orphan-drugs/</link>
	<pubDate>Tue, 29 Nov 2016 01:45:08 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=103</guid>
	<description><![CDATA[This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue here. Listen and subscribe for free on iTunes and Google Play]]></description>
	<itunes:subtitle><![CDATA[This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue here. Listen and subscribe for free on iTunes and Goog]]></itunes:subtitle>
	<content:encoded><![CDATA[This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue here. Listen and subscribe for free on iTunes and Google Play]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/103/marlene-haffner-orphan-drugs.mp3" length="23795502" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue here. Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>19:50</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue here. Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Bernard Vrijens on Dose Individualization</title>
	<link>https://ascptpod.com/podcast/episode-4-guest-bernard-vrijens/</link>
	<pubDate>Fri, 10 Jun 2016 18:20:19 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=70</guid>
	<description><![CDATA[This episode features Bernard Vrijens of WestRock Healthcare discussing quantifying the influence of adherence and dose individualization. Read his Commentary which published in the April 2016 issue here. Listen and subscribe for free on iTunes and Google Play]]></description>
	<itunes:subtitle><![CDATA[This episode features Bernard Vrijens of WestRock Healthcare discussing quantifying the influence of adherence and dose individualization. Read his Commentary which published in the April 2016 issue here. Listen and subscribe for free on iTunes and Googl]]></itunes:subtitle>
	<content:encoded><![CDATA[This episode features Bernard Vrijens of WestRock Healthcare discussing quantifying the influence of adherence and dose individualization. Read his Commentary which published in the April 2016 issue here. Listen and subscribe for free on iTunes and Google Play]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/70/episode-4-guest-bernard-vrijens.mp3" length="17770853" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Bernard Vrijens of WestRock Healthcare discussing quantifying the influence of adherence and dose individualization. Read his Commentary which published in the April 2016 issue here. Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>7:21</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[This episode features Bernard Vrijens of WestRock Healthcare discussing quantifying the influence of adherence and dose individualization. Read his Commentary which published in the April 2016 issue here. Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Daniel Hertz on Pharmacogenetics</title>
	<link>https://ascptpod.com/podcast/episode-1-pharmacogenetics-guest-dr-daniel-hertz/</link>
	<pubDate>Thu, 21 Apr 2016 18:17:06 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=67</guid>
	<description><![CDATA[This episode features Daniel Hertz of the University of Michigan College of Pharmacy discussing pharmacogenetics and its potential role in screening and treating patients. Read his commentary from the February 2016 issue on Precision Medicine here. Listen and subscribe for free on iTunes and Google Play]]></description>
	<itunes:subtitle><![CDATA[This episode features Daniel Hertz of the University of Michigan College of Pharmacy discussing pharmacogenetics and its potential role in screening and treating patients. Read his commentary from the February 2016 issue on Precision Medicine here. Liste]]></itunes:subtitle>
	<content:encoded><![CDATA[This episode features Daniel Hertz of the University of Michigan College of Pharmacy discussing pharmacogenetics and its potential role in screening and treating patients. Read his commentary from the February 2016 issue on Precision Medicine here. Listen and subscribe for free on iTunes and Google Play]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/67/episode-1-pharmacogenetics-guest-dr-daniel-hertz.mp3" length="47673115" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Daniel Hertz of the University of Michigan College of Pharmacy discussing pharmacogenetics and its potential role in screening and treating patients. Read his commentary from the February 2016 issue on Precision Medicine here. Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>24:46</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[This episode features Daniel Hertz of the University of Michigan College of Pharmacy discussing pharmacogenetics and its potential role in screening and treating patients. Read his commentary from the February 2016 issue on Precision Medicine here. Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Aaron Kesselheim on the 21st Century Cures Act</title>
	<link>https://ascptpod.com/podcast/episode-2-21st-century-cures-act-guest-dr-aaron-kesselheim/</link>
	<pubDate>Tue, 01 Dec 2015 19:18:03 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=68</guid>
	<description><![CDATA[This episode features Aaron S. Kesselheim of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital discussing the 21st Century Cures Act. Read his commentary in CPT here. Listen and subscribe for free on iTunes and Google Play]]></description>
	<itunes:subtitle><![CDATA[This episode features Aaron S. Kesselheim of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital discussing the 21st Century Cures Act. Read his commentary in CPT here. Listen and subscribe for free on iTunes and Go]]></itunes:subtitle>
	<content:encoded><![CDATA[This episode features Aaron S. Kesselheim of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital discussing the 21st Century Cures Act. Read his commentary in CPT here. Listen and subscribe for free on iTunes and Google Play]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/68/episode-2-21st-century-cures-act-guest-dr-aaron-kesselheim.mp3" length="34620877" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Aaron S. Kesselheim of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital discussing the 21st Century Cures Act. Read his commentary in CPT here. Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>14:23</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[This episode features Aaron S. Kesselheim of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital discussing the 21st Century Cures Act. Read his commentary in CPT here. Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Michelle Roth-Cline on Microdosing Studies in Children</title>
	<link>https://ascptpod.com/podcast/episode-3-microdosing-studies-children-dr-michelle-roth-cline/</link>
	<pubDate>Tue, 15 Sep 2015 18:19:10 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=69</guid>
	<description><![CDATA[This episode features Michelle Roth-Cline, ‎Pediatric Ethicist in the Office of Pediatric Therapeutics at the FDA, discussing her Commentary &#8220;Microdosing Studies in Children: A US Regulatory Perspective&#8221; which published in the September 2016 issue of CPT. Read the commentary here. Listen and subscribe for free on iTunes and Google Play]]></description>
	<itunes:subtitle><![CDATA[This episode features Michelle Roth-Cline, ‎Pediatric Ethicist in the Office of Pediatric Therapeutics at the FDA, discussing her Commentary &#8220;Microdosing Studies in Children: A US Regulatory Perspective&#8221; which published in the September 2016 ]]></itunes:subtitle>
	<content:encoded><![CDATA[This episode features Michelle Roth-Cline, ‎Pediatric Ethicist in the Office of Pediatric Therapeutics at the FDA, discussing her Commentary &#8220;Microdosing Studies in Children: A US Regulatory Perspective&#8221; which published in the September 2016 issue of CPT. Read the commentary here. Listen and subscribe for free on iTunes and Google Play]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/69/episode-3-microdosing-studies-children-dr-michelle-roth-cline.mp3" length="22752926" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Michelle Roth-Cline, ‎Pediatric Ethicist in the Office of Pediatric Therapeutics at the FDA, discussing her Commentary &#8220;Microdosing Studies in Children: A US Regulatory Perspective&#8221; which published in the September 2016 issue of CPT. Read the commentary here. Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>9:26</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[This episode features Michelle Roth-Cline, ‎Pediatric Ethicist in the Office of Pediatric Therapeutics at the FDA, discussing her Commentary &#8220;Microdosing Studies in Children: A US Regulatory Perspective&#8221; which published in the September 2016 issue of CPT. Read the commentary here. Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Mark Ware on Medical Education on Cannabis and Cannabinoids</title>
	<link>https://ascptpod.com/podcast/mark-ware-medical-education-cannabis-cannabinoids/</link>
	<pubDate>Sat, 20 Jun 2015 03:44:23 +0000</pubDate>
	<dc:creator><![CDATA[ASCPT Podcast Channel]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=97</guid>
	<description><![CDATA[This episode features Mark A. Ware of McGill University discussing perspectives, challenges, and opportunities related to medical education on cannabis and cannabinoids. Read the article here. Listen and subscribe for free on iTunes and Google Play]]></description>
	<itunes:subtitle><![CDATA[This episode features Mark A. Ware of McGill University discussing perspectives, challenges, and opportunities related to medical education on cannabis and cannabinoids. Read the article here. Listen and subscribe for free on iTunes and Google Play]]></itunes:subtitle>
	<content:encoded><![CDATA[This episode features Mark A. Ware of McGill University discussing perspectives, challenges, and opportunities related to medical education on cannabis and cannabinoids. Read the article here. Listen and subscribe for free on iTunes and Google Play]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/97/mark-ware-medical-education-cannabis-cannabinoids.mp3" length="17545442" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Mark A. Ware of McGill University discussing perspectives, challenges, and opportunities related to medical education on cannabis and cannabinoids. Read the article here. Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>14:37</itunes:duration>
	<itunes:author><![CDATA[ASCPT Podcast Channel]]></itunes:author>	<googleplay:description><![CDATA[This episode features Mark A. Ware of McGill University discussing perspectives, challenges, and opportunities related to medical education on cannabis and cannabinoids. Read the article here. Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>
	</channel>
</rss>
